General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - Section on recent mergers & acquisitions
Interventional cardiology procedures increasingly require auxiliary diagnostic screening, so that the type and extent of the lesion can be better assessed before stent placement. IVUS catheters fulfill this need by providing images of the lesion from inside the artery. These catheters are generally used during angioplasties for screening the target lesion for stent placement confirmation, likelihood of restenosis and plaque characteristics. The transducer attached to the IVUS catheter is able to provide black-and-white tri-dimensional images of different layers of the lumen, even allowing the screening of calcified areas of the vein, where stenting can be difficult. These images are generated by a process of reverberation, where sound waves created by the transducer echo back, thus enabling this information to be converted into pictures on a monitor. In addition to pre-dilation screening, IVUS catheters can also aid cardiologists in post-stenting examination. One of the advantages of using an IVUS catheter is that the device allows the visualization of the stent after its deployment. In this situation, the IVUS catheter is capable of checking if the stent matched the diameter of the lesion, decreasing the likelihood of a thrombosis caused by partial stent expansion, which is a rising concern amongst physicians. In addition, IVUS can be used for detecting stent fracture and other post stenting complications. The penetration rate of IVUS is still growing despite the introduction of a competing imaging modality, optical coherence tomography (OCT). Competition from OCT will limit sales of both IVUS catheters and consoles, however, it is not likely to decrease the penetration rate of IVUS by any substantial measure because many cath labs will choose to have both IVUS and OCT consoles, especially those consoles that also have fractional flow reserve (FFR) functionality.
Abstract The vast majority of IVUS catheters are used immediately before, during or after an angioplasty procedure. Intravascular ultrasound (IVUS) catheters are used in conjunction with minimally invasive cardiovascular procedures. Procedures utilizing IVUS catheters must be performed in catheterization laboratories or cath labs that have an IVUS console. These consoles are typically integrated into the cath lab infrastructure and are not portable. The introduction of IVUS consoles to an increasingly large percentage of cath labs in Japan, as well as the introduction of reimbursement programs for IVUS devices, allowed the number of IVUS catheters used to grow rapidly since 2002.
Our reports have been used by over 10K customers, including:
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
175 pages •
By The Business Research Company
• May 2021
Major players in the fertility services market are Merck KGaA, Care Fertility, INVO Bioscience, Vitrolife, Monash IVF Group, Carolinas Fertility Institute, IntegraMed, Inc., New Hope Fertility Center, and Apollo Hospitals Enterprise Ltd. The global fertility services market is expected to grow from $16.948 billion in 2020 to $18.475...
The Asia Pacific 3D Ultrasound Market would witness market growth of 9.7% CAGR during the forecast period (2020-2026). In the Asia Pacific, the 3D ultrasound market is going to observe the fastest growth rate during the forecast period. An increasing number of patient pools and a growing inclination for minimally invasive medical procedures...
Innovative Leaders are Transforming the Cardiovascular Patient Journey Over the last few decades, modernization-driven lifestyle changes have had major implications on people’s health and well-being.Today, chronic health condition such as cardiovascular diseases (CVD) claim more lives than all forms of cancer combined,...
Global Proton Therapy Market & Forecast (12 Countries Market Data), Patients Treated at Proton Therapy Centers, Reimbursement Policies Global Proton Therapy market will surpass US$ 18 Billion by 2018. According to Renub research analysis, the global proton therapy market will be growing at a rapid...
This IDC Market Note is a translation of the Japanese document IDC #JPJ44156618. NTT Data acquired Dell Services in November 2016 and expanded its presence in North America dramatically. After that, it has consolidated NTT DATA Inc., its then subsidiary in North America, and Dell Services, as well as articulated strategy and implementation...
Summary BioTelemetry Research (BioTelemetry), formerly Cardiocore, is a subsidiary of BioTelemetry, Inc., healthcare service provider that offers imaging services. The center offers cardiac testing services such as imaging and respiratory testing services. Its services comprise electrocardiography, holter monitoring, ambulatory...
Summary Mount Sinai Medical Center (Mount Sinai) is a healthcare service provider that offers neuroscience, cardiology, oncology and orthopedic solutions. The hospital offers services such as adult congenital heart disease clinic, aortic surgery, cardiac anesthesia, cardiac catheterization, cardiac rehabilitation, cardiac surgery,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.